title: Expression of Testis Specific Genes TSGA10, TEX101 and ODF3 in Breast Cancer.
abstract: BACKGROUND
  Breast cancer is the most common malignancy in women around the world so finding new biomarkers for early detection and also study on molecular aspects of breast cancer is valuable. Cancer testis genes are a group of genes expressed solely in testis and in a range of human malignancies.
  
  
  OBJECTIVE
  In this study we determined the expression of cancer testis genes Tsga10, TEX101 and ODF3 in patients with breast cancer.
  
  
  METHODS
  Fifty patients with breast cancer were enrolled in this study. Breast cancer cell lines MCF-7 and MDA-MB-231 were also used to determine the expression of testis cancer genes. For both patients and cell lines, cancer testis genes of TSGA10, TEX101 and ODF3 were determined by RT-PCR. The presence of auto antibody against these genes in patients' serums was carried on by ELISA method.
  
  
  RESULTS
  Seventy percent of patients showed TSGA10 expression but none of them showed expression of TEX101 and ODF3. Fourteen percent of patients were positive for anti TSGA10 but all patients were negative for anti TEX101 and anti ODF3. Both of breast cancer cell lines exhibited very strong expression of TSGA10.
  
  
  CONCLUSIONS
  Because of the important roles of Tsga10 in cell proliferation, we concluded that this gene may have a role in proliferation and survival of breast cancer cells and could be used for diagnosis and immunotherapy of breast cancer.
authors: Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran.
authors: Mehdi
authors: M
authors: Dianatpour
authors: Parvin
authors: P
authors: Mehdipour
authors: Karim
authors: K
authors: Nayernia
authors: Maryam-Beigom
authors: MB
authors: Mobasheri
authors: Soudeh
authors: S
authors: Ghafouri-Fard
authors: Shahram
authors: S
authors: Savad
authors: Mohammad Hossein
authors: MH
authors: Modarressi
keywords: Breast Cancer; Gene; ODF3; TEX101; TSGA10; Testis
references: Nat Rev Cancer. 2005 Aug;5(8):615-25
references: 16034368
references: Ann Oncol. 2011 Jan;22(1):98-103
references: 20610479
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3362-4
references: 14713968
references: Eur J Cancer. 2012 Jan;48(1):12-23
references: 21741824
references: Cancer Immunol Immunother. 2011 Jul;60(7):999-1007
references: 21465317
references: Br J Dermatol. 2010 Apr;162(4):772-9
references: 19886887
references: J Exp Clin Cancer Res. 2011 Jan 06;30:2
references: 21211023
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D816-9
references: 18838390
references: Gene. 2001 Jan 10;262(1-2):249-55
references: 11179690
references: Microsc Res Tech. 1992 Jan 1;20(1):3-33
references: 1611148
references: Cancer Immun. 2004 Jan 23;4:1
references: 14738373
references: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20422-7
references: 19088187
references: Arch Med Res. 2010 Apr;41(3):195-200
references: 20682177
references: Arch Iran Med. 2009 Jul;12(4):395-404
references: 19566358
references: Cancer Res. 2010 Jun 1;70(11):4569-79
references: 20460541
references: Cancer Detect Prev. 2007;31(4):296-302
references: 17920210
references: PLoS One. 2011 Mar 18;6(3):e17876
references: 21437249